321 related articles for article (PubMed ID: 27185075)
1. Serum I-FABP Detects Gluten Responsiveness in Adult Celiac Disease Patients on a Short-Term Gluten Challenge.
Adriaanse MP; Leffler DA; Kelly CP; Schuppan D; Najarian RM; Goldsmith JD; Buurman WA; Vreugdenhil AC
Am J Gastroenterol; 2016 Jul; 111(7):1014-22. PubMed ID: 27185075
[TBL] [Abstract][Full Text] [Related]
2. Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
Adriaanse MP; Tack GJ; Passos VL; Damoiseaux JG; Schreurs MW; van Wijck K; Riedl RG; Masclee AA; Buurman WA; Mulder CJ; Vreugdenhil AC
Aliment Pharmacol Ther; 2013 Feb; 37(4):482-90. PubMed ID: 23289539
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.
Leffler D; Schuppan D; Pallav K; Najarian R; Goldsmith JD; Hansen J; Kabbani T; Dennis M; Kelly CP
Gut; 2013 Jul; 62(7):996-1004. PubMed ID: 22619366
[TBL] [Abstract][Full Text] [Related]
4. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
5. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
6. Monitoring patients with celiac disease on gluten free diet: different outcomes comparing three tissue transglutaminase IgA assays.
Mulder AHL; Castelijn DAR; van der Pol P; Vermeer M; Hollander JC; Kuiper T; Bijnens C; Bontkes HJ; Damoiseaux J
Clin Chem Lab Med; 2024 Mar; 62(4):674-681. PubMed ID: 37943101
[TBL] [Abstract][Full Text] [Related]
7. Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease.
Monzani A; Rapa A; Fonio P; Tognato E; Panigati L; Oderda G
J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):55-60. PubMed ID: 21694536
[TBL] [Abstract][Full Text] [Related]
8. Serological assessment for celiac disease in IgA deficient adults.
Wang N; Truedsson L; Elvin K; Andersson BA; Rönnelid J; Mincheva-Nilsson L; Lindkvist A; Ludvigsson JF; Hammarström L; Dahle C
PLoS One; 2014; 9(4):e93180. PubMed ID: 24709954
[TBL] [Abstract][Full Text] [Related]
9. ACG clinical guidelines: diagnosis and management of celiac disease.
Rubio-Tapia A; Hill ID; Kelly CP; Calderwood AH; Murray JA;
Am J Gastroenterol; 2013 May; 108(5):656-76; quiz 677. PubMed ID: 23609613
[TBL] [Abstract][Full Text] [Related]
10. [Significance of a method for determination of deamidated gliadin peptide in the diagnosis of celiac disease].
Sabelnikova EA; Parfenov AI; Krums LM; Gudkova RB; Sagynbaeva VE; Bykova SV
Ter Arkh; 2014; 86(2):39-43. PubMed ID: 24772506
[TBL] [Abstract][Full Text] [Related]
11. A prospective, double-blind, placebo-controlled trial to establish a safe gluten threshold for patients with celiac disease.
Catassi C; Fabiani E; Iacono G; D'Agate C; Francavilla R; Biagi F; Volta U; Accomando S; Picarelli A; De Vitis I; Pianelli G; Gesuita R; Carle F; Mandolesi A; Bearzi I; Fasano A
Am J Clin Nutr; 2007 Jan; 85(1):160-6. PubMed ID: 17209192
[TBL] [Abstract][Full Text] [Related]
12. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
[TBL] [Abstract][Full Text] [Related]
13. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
14. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of a new point-of-care screening assay for celiac disease.
Benkebil F; Combescure C; Anghel SI; Besson Duvanel C; Schäppi MG
World J Gastroenterol; 2013 Aug; 19(31):5111-7. PubMed ID: 23964145
[TBL] [Abstract][Full Text] [Related]
16. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
17. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
Husby S; Murray JA; Katzka DA
Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease.
Picarelli A; Di Tola M; Marino M; Libanori V; Borghini R; Salvi E; Donato G; Vitolo D; Tiberti A; Marcheggiano A; Bassotti G; Corazziari E
Transl Res; 2013 Mar; 161(3):172-80. PubMed ID: 23177794
[TBL] [Abstract][Full Text] [Related]
19. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet.
Not T; Ziberna F; Vatta S; Quaglia S; Martelossi S; Villanacci V; Marzari R; Florian F; Vecchiet M; Sulic AM; Ferrara F; Bradbury A; Sblattero D; Ventura A
Gut; 2011 Nov; 60(11):1487-93. PubMed ID: 21471568
[TBL] [Abstract][Full Text] [Related]
20. Progress towards non-invasive diagnosis and follow-up of celiac disease in children; a prospective multicentre study to the usefulness of plasma I-FABP.
Adriaanse MPM; Mubarak A; Riedl RG; Ten Kate FJW; Damoiseaux JGMC; Buurman WA; Houwen RHJ; Vreugdenhil ACE;
Sci Rep; 2017 Aug; 7(1):8671. PubMed ID: 28819290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
